Viewing Study NCT02991651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-18 @ 4:26 AM
Study NCT ID: NCT02991651
Status: TERMINATED
Last Update Posted: 2025-05-14
First Post: 2016-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
Sponsor: Io Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer, Nonsmall Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RXR agonist IRX4204 erlotinib View